LYNX1 CAPITAL MANAGEMENT LP purchased 5.4% of their position (32.01K shares) of PASSAGE BIO, INC. on the open market
Open‑market purchase worth $223.7K — a moderate purchase. The strongest form of insider conviction signal.
P · 3 purchases
Filed: 9/15/2025ACC: 0000902664-25-004079
10% Owner
Since Aug 2024
+32.01K
Net shares
Net buyer
$223.7K
Total acquired
3
Open market trades
3B · 0S
3
Total transactions
32.01K acquired
Non-Derivative Transactions3
Common stock, $0.0001 par value per share (Common Stock)
Indirect
Shares
+325.00
Price / share
$6.96
Trade value
$2.26K
% of position
0.1%
9/11/2025
591.70K→592.02K
Common Stock
Indirect
Shares
+19.78K
Price / share
$6.99
Trade value
$138.30K
% of position
3.3%
9/12/2025
592.02K→611.80K
Common Stock
Indirect
Shares
+11.90K
Price / share
$6.99
Trade value
$83.18K
% of position
1.9%
9/15/2025
611.80K→623.70K
Total
Net shares
+32.01K
Net value
$223.73K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common stock, $0.0001 par value per share (Common Stock) Indirect | 9/11/2025 | P · Purchase | +325.00 | $6.96 | $2.26K | 0.1% | 591.70K | 592.02K |
| Common Stock Indirect | 9/12/2025 | P · Purchase | +19.78K | $6.99 | $138.30K | 3.3% | 592.02K | 611.80K |
| Common Stock Indirect | 9/15/2025 | P · Purchase | +11.90K | $6.99 | $83.18K | 1.9% | 611.80K | 623.70K |
| Total | +32.01K | $223.73K | ||||||
Derivative Transactions0
No derivative transactions reported